M. Topcul Et Al. , "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells," ONCOLOGY REPORTS , vol.40, no.1, pp.527-535, 2018
Topcul, M. Et Al. 2018. In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells. ONCOLOGY REPORTS , vol.40, no.1 , 527-535.
Topcul, M., Cetin, I., Turan, S., & Ozar, M. O. K., (2018). In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells. ONCOLOGY REPORTS , vol.40, no.1, 527-535.
Topcul, Mehmet Et Al. "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells," ONCOLOGY REPORTS , vol.40, no.1, 527-535, 2018
Topcul, Mehmet Et Al. "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells." ONCOLOGY REPORTS , vol.40, no.1, pp.527-535, 2018
Topcul, M. Et Al. (2018) . "In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells." ONCOLOGY REPORTS , vol.40, no.1, pp.527-535.
@article{article, author={Mehmet Topcul Et Al. }, title={In vitro cytotoxic effect of PARP inhibitor alone and in combination with nab-paclitaxel on triple-negative and luminal A breast cancer cells}, journal={ONCOLOGY REPORTS}, year=2018, pages={527-535} }